Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Ad.p53-DC vaccine |
Trade Name | |
Synonyms | INGN-225 |
Drug Descriptions |
INGN-225 (Ad.p53-DC vaccine) is an adenoviral-p53 dendritic cell vaccine, which potentially induces a cytotoxic immune response against tumor cells over expressing Tp53 (PMID: 20420527). |
DrugClasses | p53 Vaccine 5 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Ad.p53-DC vaccine | Ad.p53-DC vaccine | 1 | 0 |
Ad.p53-DC vaccine + Indoximod | Ad.p53-DC vaccine Indoximod | 0 | 1 |
Ad.p53-DC vaccine + Ipilimumab + Nivolumab | Ad.p53-DC vaccine Ipilimumab Nivolumab | 0 | 1 |